EmpressTx

Empress Therapeutics partners with drug discovery teams to enhance target deconvolution, identify liabilities, and prioritize molecules efficiently from hit triage to candidate nomination. The company utilizes an advanced Perturb-seq platform to transform CRISPR-based single-cell functional genomics, enabling high-throughput analysis of numerous hy... potheses simultaneously. By integrating automated functional genomics, chemoproteomics, and multi-omics with causal machine learning, Empress provides critical insights into drug activity, efficacy, and risk. Their services aim to support R&D teams in moving beyond traditional target lists to achieve experimentally grounded understanding.Read More